Global Biosimilars of Rituximab Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Biosimilars of Rituximab Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Biosimilars of Rituximab by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Biosimilars of Rituximab by Country/Region, 2017, 2022 & 2028

2.2 Biosimilars of Rituximab Segment by Type

2.2.1 500mg

2.2.2 100mg

2.2.3 Other

2.3 Biosimilars of Rituximab Sales by Type

2.3.1 Global Biosimilars of Rituximab Sales Market Share by Type (2017-2022)

2.3.2 Global Biosimilars of Rituximab Revenue and Market Share by Type (2017-2022)

2.3.3 Global Biosimilars of Rituximab Sale Price by Type (2017-2022)

2.4 Biosimilars of Rituximab Segment by Application

2.4.1 Hospital Pharmacy

2.4.2 Retail Pharmacy

2.5 Biosimilars of Rituximab Sales by Application

2.5.1 Global Biosimilars of Rituximab Sale Market Share by Application (2017-2022)

2.5.2 Global Biosimilars of Rituximab Revenue and Market Share by Application (2017-2022)

2.5.3 Global Biosimilars of Rituximab Sale Price by Application (2017-2022)

3 Global Biosimilars of Rituximab by Company

3.1 Global Biosimilars of Rituximab Breakdown Data by Company

3.1.1 Global Biosimilars of Rituximab Annual Sales by Company (2020-2022)

3.1.2 Global Biosimilars of Rituximab Sales Market Share by Company (2020-2022)

3.2 Global Biosimilars of Rituximab Annual Revenue by Company (2020-2022)

3.2.1 Global Biosimilars of Rituximab Revenue by Company (2020-2022)

3.2.2 Global Biosimilars of Rituximab Revenue Market Share by Company (2020-2022)

3.3 Global Biosimilars of Rituximab Sale Price by Company

3.4 Key Manufacturers Biosimilars of Rituximab Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Biosimilars of Rituximab Product Location Distribution

3.4.2 Players Biosimilars of Rituximab Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Biosimilars of Rituximab by Geographic Region

4.1 World Historic Biosimilars of Rituximab Market Size by Geographic Region (2017-2022)

4.1.1 Global Biosimilars of Rituximab Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Biosimilars of Rituximab Annual Revenue by Geographic Region

4.2 World Historic Biosimilars of Rituximab Market Size by Country/Region (2017-2022)

4.2.1 Global Biosimilars of Rituximab Annual Sales by Country/Region (2017-2022)

4.2.2 Global Biosimilars of Rituximab Annual Revenue by Country/Region

4.3 Americas Biosimilars of Rituximab Sales Growth

4.4 APAC Biosimilars of Rituximab Sales Growth

4.5 Europe Biosimilars of Rituximab Sales Growth

4.6 Middle East & Africa Biosimilars of Rituximab Sales Growth

5 Americas

5.1 Americas Biosimilars of Rituximab Sales by Country

5.1.1 Americas Biosimilars of Rituximab Sales by Country (2017-2022)

5.1.2 Americas Biosimilars of Rituximab Revenue by Country (2017-2022)

5.2 Americas Biosimilars of Rituximab Sales by Type

5.3 Americas Biosimilars of Rituximab Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Biosimilars of Rituximab Sales by Region

6.1.1 APAC Biosimilars of Rituximab Sales by Region (2017-2022)

6.1.2 APAC Biosimilars of Rituximab Revenue by Region (2017-2022)

6.2 APAC Biosimilars of Rituximab Sales by Type

6.3 APAC Biosimilars of Rituximab Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Biosimilars of Rituximab by Country

7.1.1 Europe Biosimilars of Rituximab Sales by Country (2017-2022)

7.1.2 Europe Biosimilars of Rituximab Revenue by Country (2017-2022)

7.2 Europe Biosimilars of Rituximab Sales by Type

7.3 Europe Biosimilars of Rituximab Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Biosimilars of Rituximab by Country

8.1.1 Middle East & Africa Biosimilars of Rituximab Sales by Country (2017-2022)

8.1.2 Middle East & Africa Biosimilars of Rituximab Revenue by Country (2017-2022)

8.2 Middle East & Africa Biosimilars of Rituximab Sales by Type

8.3 Middle East & Africa Biosimilars of Rituximab Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Biosimilars of Rituximab

10.3 Manufacturing Process Analysis of Biosimilars of Rituximab

10.4 Industry Chain Structure of Biosimilars of Rituximab

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Biosimilars of Rituximab Distributors

11.3 Biosimilars of Rituximab Customer

12 World Forecast Review for Biosimilars of Rituximab by Geographic Region

12.1 Global Biosimilars of Rituximab Market Size Forecast by Region

12.1.1 Global Biosimilars of Rituximab Forecast by Region (2023-2028)

12.1.2 Global Biosimilars of Rituximab Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Biosimilars of Rituximab Forecast by Type

12.7 Global Biosimilars of Rituximab Forecast by Application

13 Key Players Analysis

13.1 Amgen

13.1.1 Amgen Company Information

13.1.2 Amgen Biosimilars of Rituximab Product Offered

13.1.3 Amgen Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Amgen Main Business Overview

13.1.5 Amgen Latest Developments

13.2 AryoGen Pharmed

13.2.1 AryoGen Pharmed Company Information

13.2.2 AryoGen Pharmed Biosimilars of Rituximab Product Offered

13.2.3 AryoGen Pharmed Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 AryoGen Pharmed Main Business Overview

13.2.5 AryoGen Pharmed Latest Developments

13.3 Biocad

13.3.1 Biocad Company Information

13.3.2 Biocad Biosimilars of Rituximab Product Offered

13.3.3 Biocad Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Biocad Main Business Overview

13.3.5 Biocad Latest Developments

13.4 Cadila Pharmaceuticals

13.4.1 Cadila Pharmaceuticals Company Information

13.4.2 Cadila Pharmaceuticals Biosimilars of Rituximab Product Offered

13.4.3 Cadila Pharmaceuticals Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Cadila Pharmaceuticals Main Business Overview

13.4.5 Cadila Pharmaceuticals Latest Developments

13.5 Celltrion

13.5.1 Celltrion Company Information

13.5.2 Celltrion Biosimilars of Rituximab Product Offered

13.5.3 Celltrion Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Celltrion Main Business Overview

13.5.5 Celltrion Latest Developments

13.6 Dr Reddy’s Laboratories

13.6.1 Dr Reddy’s Laboratories Company Information

13.6.2 Dr Reddy’s Laboratories Biosimilars of Rituximab Product Offered

13.6.3 Dr Reddy’s Laboratories Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Dr Reddy’s Laboratories Main Business Overview

13.6.5 Dr Reddy’s Laboratories Latest Developments

13.7 Teva

13.7.1 Teva Company Information

13.7.2 Teva Biosimilars of Rituximab Product Offered

13.7.3 Teva Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Teva Main Business Overview

13.7.5 Teva Latest Developments

13.8 Hetero Group

13.8.1 Hetero Group Company Information

13.8.2 Hetero Group Biosimilars of Rituximab Product Offered

13.8.3 Hetero Group Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Hetero Group Main Business Overview

13.8.5 Hetero Group Latest Developments

13.9 Innovent Biologics

13.9.1 Innovent Biologics Company Information

13.9.2 Innovent Biologics Biosimilars of Rituximab Product Offered

13.9.3 Innovent Biologics Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Innovent Biologics Main Business Overview

13.9.5 Innovent Biologics Latest Developments

13.10 Intas Biopharmaceuticals

13.10.1 Intas Biopharmaceuticals Company Information

13.10.2 Intas Biopharmaceuticals Biosimilars of Rituximab Product Offered

13.10.3 Intas Biopharmaceuticals Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Intas Biopharmaceuticals Main Business Overview

13.10.5 Intas Biopharmaceuticals Latest Developments

13.11 Mylan

13.11.1 Mylan Company Information

13.11.2 Mylan Biosimilars of Rituximab Product Offered

13.11.3 Mylan Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Mylan Main Business Overview

13.11.5 Mylan Latest Developments

13.12 Probiomed

13.12.1 Probiomed Company Information

13.12.2 Probiomed Biosimilars of Rituximab Product Offered

13.12.3 Probiomed Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Probiomed Main Business Overview

13.12.5 Probiomed Latest Developments

13.13 TRPharma

13.13.1 TRPharma Company Information

13.13.2 TRPharma Biosimilars of Rituximab Product Offered

13.13.3 TRPharma Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 TRPharma Main Business Overview

13.13.5 TRPharma Latest Developments

13.14 Zenotech Laboratories

13.14.1 Zenotech Laboratories Company Information

13.14.2 Zenotech Laboratories Biosimilars of Rituximab Product Offered

13.14.3 Zenotech Laboratories Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Zenotech Laboratories Main Business Overview

13.14.5 Zenotech Laboratories Latest Developments

14 Research Findings and Conclusion

Table 1. Biosimilars of Rituximab Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Biosimilars of Rituximab Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 500mg

Table 4. Major Players of 100mg

Table 5. Major Players of Other

Table 6. Global Biosimilars of Rituximab Sales by Type (2017-2022) & (K Units)

Table 7. Global Biosimilars of Rituximab Sales Market Share by Type (2017-2022)

Table 8. Global Biosimilars of Rituximab Revenue by Type (2017-2022) & ($ million)

Table 9. Global Biosimilars of Rituximab Revenue Market Share by Type (2017-2022)

Table 10. Global Biosimilars of Rituximab Sale Price by Type (2017-2022) & (US$/Unit)

Table 11. Global Biosimilars of Rituximab Sales by Application (2017-2022) & (K Units)

Table 12. Global Biosimilars of Rituximab Sales Market Share by Application (2017-2022)

Table 13. Global Biosimilars of Rituximab Revenue by Application (2017-2022)

Table 14. Global Biosimilars of Rituximab Revenue Market Share by Application (2017-2022)

Table 15. Global Biosimilars of Rituximab Sale Price by Application (2017-2022) & (US$/Unit)

Table 16. Global Biosimilars of Rituximab Sales by Company (2020-2022) & (K Units)

Table 17. Global Biosimilars of Rituximab Sales Market Share by Company (2020-2022)

Table 18. Global Biosimilars of Rituximab Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Biosimilars of Rituximab Revenue Market Share by Company (2020-2022)

Table 20. Global Biosimilars of Rituximab Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers Biosimilars of Rituximab Producing Area Distribution and Sales Area

Table 22. Players Biosimilars of Rituximab Products Offered

Table 23. Biosimilars of Rituximab Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Biosimilars of Rituximab Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Biosimilars of Rituximab Sales Market Share Geographic Region (2017-2022)

Table 28. Global Biosimilars of Rituximab Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Biosimilars of Rituximab Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Biosimilars of Rituximab Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Biosimilars of Rituximab Sales Market Share by Country/Region (2017-2022)

Table 32. Global Biosimilars of Rituximab Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Biosimilars of Rituximab Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Biosimilars of Rituximab Sales by Country (2017-2022) & (K Units)

Table 35. Americas Biosimilars of Rituximab Sales Market Share by Country (2017-2022)

Table 36. Americas Biosimilars of Rituximab Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Biosimilars of Rituximab Revenue Market Share by Country (2017-2022)

Table 38. Americas Biosimilars of Rituximab Sales by Type (2017-2022) & (K Units)

Table 39. Americas Biosimilars of Rituximab Sales Market Share by Type (2017-2022)

Table 40. Americas Biosimilars of Rituximab Sales by Application (2017-2022) & (K Units)

Table 41. Americas Biosimilars of Rituximab Sales Market Share by Application (2017-2022)

Table 42. APAC Biosimilars of Rituximab Sales by Region (2017-2022) & (K Units)

Table 43. APAC Biosimilars of Rituximab Sales Market Share by Region (2017-2022)

Table 44. APAC Biosimilars of Rituximab Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Biosimilars of Rituximab Revenue Market Share by Region (2017-2022)

Table 46. APAC Biosimilars of Rituximab Sales by Type (2017-2022) & (K Units)

Table 47. APAC Biosimilars of Rituximab Sales Market Share by Type (2017-2022)

Table 48. APAC Biosimilars of Rituximab Sales by Application (2017-2022) & (K Units)

Table 49. APAC Biosimilars of Rituximab Sales Market Share by Application (2017-2022)

Table 50. Europe Biosimilars of Rituximab Sales by Country (2017-2022) & (K Units)

Table 51. Europe Biosimilars of Rituximab Sales Market Share by Country (2017-2022)

Table 52. Europe Biosimilars of Rituximab Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Biosimilars of Rituximab Revenue Market Share by Country (2017-2022)

Table 54. Europe Biosimilars of Rituximab Sales by Type (2017-2022) & (K Units)

Table 55. Europe Biosimilars of Rituximab Sales Market Share by Type (2017-2022)

Table 56. Europe Biosimilars of Rituximab Sales by Application (2017-2022) & (K Units)

Table 57. Europe Biosimilars of Rituximab Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Biosimilars of Rituximab Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Biosimilars of Rituximab Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Biosimilars of Rituximab Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Biosimilars of Rituximab Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Biosimilars of Rituximab Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Biosimilars of Rituximab Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Biosimilars of Rituximab Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Biosimilars of Rituximab Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Biosimilars of Rituximab

Table 67. Key Market Challenges & Risks of Biosimilars of Rituximab

Table 68. Key Industry Trends of Biosimilars of Rituximab

Table 69. Biosimilars of Rituximab Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Biosimilars of Rituximab Distributors List

Table 72. Biosimilars of Rituximab Customer List

Table 73. Global Biosimilars of Rituximab Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Biosimilars of Rituximab Sales Market Forecast by Region

Table 75. Global Biosimilars of Rituximab Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Biosimilars of Rituximab Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Biosimilars of Rituximab Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Biosimilars of Rituximab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Biosimilars of Rituximab Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Biosimilars of Rituximab Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Biosimilars of Rituximab Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Biosimilars of Rituximab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Biosimilars of Rituximab Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Biosimilars of Rituximab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Biosimilars of Rituximab Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Biosimilars of Rituximab Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Biosimilars of Rituximab Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Biosimilars of Rituximab Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Biosimilars of Rituximab Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Biosimilars of Rituximab Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Biosimilars of Rituximab Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Biosimilars of Rituximab Revenue Market Share Forecast by Application (2023-2028)

Table 93. Amgen Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors

Table 94. Amgen Biosimilars of Rituximab Product Offered

Table 95. Amgen Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. Amgen Main Business

Table 97. Amgen Latest Developments

Table 98. AryoGen Pharmed Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors

Table 99. AryoGen Pharmed Biosimilars of Rituximab Product Offered

Table 100. AryoGen Pharmed Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. AryoGen Pharmed Main Business

Table 102. AryoGen Pharmed Latest Developments

Table 103. Biocad Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors

Table 104. Biocad Biosimilars of Rituximab Product Offered

Table 105. Biocad Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. Biocad Main Business

Table 107. Biocad Latest Developments

Table 108. Cadila Pharmaceuticals Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors

Table 109. Cadila Pharmaceuticals Biosimilars of Rituximab Product Offered

Table 110. Cadila Pharmaceuticals Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. Cadila Pharmaceuticals Main Business

Table 112. Cadila Pharmaceuticals Latest Developments

Table 113. Celltrion Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors

Table 114. Celltrion Biosimilars of Rituximab Product Offered

Table 115. Celltrion Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. Celltrion Main Business

Table 117. Celltrion Latest Developments

Table 118. Dr Reddy’s Laboratories Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors

Table 119. Dr Reddy’s Laboratories Biosimilars of Rituximab Product Offered

Table 120. Dr Reddy’s Laboratories Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 121. Dr Reddy’s Laboratories Main Business

Table 122. Dr Reddy’s Laboratories Latest Developments

Table 123. Teva Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors

Table 124. Teva Biosimilars of Rituximab Product Offered

Table 125. Teva Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 126. Teva Main Business

Table 127. Teva Latest Developments

Table 128. Hetero Group Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors

Table 129. Hetero Group Biosimilars of Rituximab Product Offered

Table 130. Hetero Group Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 131. Hetero Group Main Business

Table 132. Hetero Group Latest Developments

Table 133. Innovent Biologics Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors

Table 134. Innovent Biologics Biosimilars of Rituximab Product Offered

Table 135. Innovent Biologics Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 136. Innovent Biologics Main Business

Table 137. Innovent Biologics Latest Developments

Table 138. Intas Biopharmaceuticals Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors

Table 139. Intas Biopharmaceuticals Biosimilars of Rituximab Product Offered

Table 140. Intas Biopharmaceuticals Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 141. Intas Biopharmaceuticals Main Business

Table 142. Intas Biopharmaceuticals Latest Developments

Table 143. Mylan Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors

Table 144. Mylan Biosimilars of Rituximab Product Offered

Table 145. Mylan Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 146. Mylan Main Business

Table 147. Mylan Latest Developments

Table 148. Probiomed Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors

Table 149. Probiomed Biosimilars of Rituximab Product Offered

Table 150. Probiomed Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 151. Probiomed Main Business

Table 152. Probiomed Latest Developments

Table 153. TRPharma Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors

Table 154. TRPharma Biosimilars of Rituximab Product Offered

Table 155. TRPharma Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 156. TRPharma Main Business

Table 157. TRPharma Latest Developments

Table 158. Zenotech Laboratories Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors

Table 159. Zenotech Laboratories Biosimilars of Rituximab Product Offered

Table 160. Zenotech Laboratories Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 161. Zenotech Laboratories Main Business

Table 162. Zenotech Laboratories Latest Developments

List of Figures

Figure 1. Picture of Biosimilars of Rituximab

Figure 2. Biosimilars of Rituximab Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Biosimilars of Rituximab Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Biosimilars of Rituximab Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Biosimilars of Rituximab Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 500mg

Figure 10. Product Picture of 100mg

Figure 11. Product Picture of Other

Figure 12. Global Biosimilars of Rituximab Sales Market Share by Type in 2021

Figure 13. Global Biosimilars of Rituximab Revenue Market Share by Type (2017-2022)

Figure 14. Biosimilars of Rituximab Consumed in Hospital Pharmacy

Figure 15. Global Biosimilars of Rituximab Market: Hospital Pharmacy (2017-2022) & (K Units)

Figure 16. Biosimilars of Rituximab Consumed in Retail Pharmacy

Figure 17. Global Biosimilars of Rituximab Market: Retail Pharmacy (2017-2022) & (K Units)

Figure 18. Global Biosimilars of Rituximab Sales Market Share by Application (2017-2022)

Figure 19. Global Biosimilars of Rituximab Revenue Market Share by Application in 2021

Figure 20. Biosimilars of Rituximab Revenue Market by Company in 2021 ($ Million)

Figure 21. Global Biosimilars of Rituximab Revenue Market Share by Company in 2021

Figure 22. Global Biosimilars of Rituximab Sales Market Share by Geographic Region (2017-2022)

Figure 23. Global Biosimilars of Rituximab Revenue Market Share by Geographic Region in 2021

Figure 24. Global Biosimilars of Rituximab Sales Market Share by Region (2017-2022)

Figure 25. Global Biosimilars of Rituximab Revenue Market Share by Country/Region in 2021

Figure 26. Americas Biosimilars of Rituximab Sales 2017-2022 (K Units)

Figure 27. Americas Biosimilars of Rituximab Revenue 2017-2022 ($ Millions)

Figure 28. APAC Biosimilars of Rituximab Sales 2017-2022 (K Units)

Figure 29. APAC Biosimilars of Rituximab Revenue 2017-2022 ($ Millions)

Figure 30. Europe Biosimilars of Rituximab Sales 2017-2022 (K Units)

Figure 31. Europe Biosimilars of Rituximab Revenue 2017-2022 ($ Millions)

Figure 32. Middle East & Africa Biosimilars of Rituximab Sales 2017-2022 (K Units)

Figure 33. Middle East & Africa Biosimilars of Rituximab Revenue 2017-2022 ($ Millions)

Figure 34. Americas Biosimilars of Rituximab Sales Market Share by Country in 2021

Figure 35. Americas Biosimilars of Rituximab Revenue Market Share by Country in 2021

Figure 36. United States Biosimilars of Rituximab Revenue Growth 2017-2022 ($ Millions)

Figure 37. Canada Biosimilars of Rituximab Revenue Growth 2017-2022 ($ Millions)

Figure 38. Mexico Biosimilars of Rituximab Revenue Growth 2017-2022 ($ Millions)

Figure 39. Brazil Biosimilars of Rituximab Revenue Growth 2017-2022 ($ Millions)

Figure 40. APAC Biosimilars of Rituximab Sales Market Share by Region in 2021

Figure 41. APAC Biosimilars of Rituximab Revenue Market Share by Regions in 2021

Figure 42. China Biosimilars of Rituximab Revenue Growth 2017-2022 ($ Millions)

Figure 43. Japan Biosimilars of Rituximab Revenue Growth 2017-2022 ($ Millions)

Figure 44. South Korea Biosimilars of Rituximab Revenue Growth 2017-2022 ($ Millions)

Figure 45. Southeast Asia Biosimilars of Rituximab Revenue Growth 2017-2022 ($ Millions)

Figure 46. India Biosimilars of Rituximab Revenue Growth 2017-2022 ($ Millions)

Figure 47. Australia Biosimilars of Rituximab Revenue Growth 2017-2022 ($ Millions)

Figure 48. Europe Biosimilars of Rituximab Sales Market Share by Country in 2021

Figure 49. Europe Biosimilars of Rituximab Revenue Market Share by Country in 2021

Figure 50. Germany Biosimilars of Rituximab Revenue Growth 2017-2022 ($ Millions)

Figure 51. France Biosimilars of Rituximab Revenue Growth 2017-2022 ($ Millions)

Figure 52. UK Biosimilars of Rituximab Revenue Growth 2017-2022 ($ Millions)

Figure 53. Italy Biosimilars of Rituximab Revenue Growth 2017-2022 ($ Millions)

Figure 54. Russia Biosimilars of Rituximab Revenue Growth 2017-2022 ($ Millions)

Figure 55. Middle East & Africa Biosimilars of Rituximab Sales Market Share by Country in 2021

Figure 56. Middle East & Africa Biosimilars of Rituximab Revenue Market Share by Country in 2021

Figure 57. Egypt Biosimilars of Rituximab Revenue Growth 2017-2022 ($ Millions)

Figure 58. South Africa Biosimilars of Rituximab Revenue Growth 2017-2022 ($ Millions)

Figure 59. Israel Biosimilars of Rituximab Revenue Growth 2017-2022 ($ Millions)

Figure 60. Turkey Biosimilars of Rituximab Revenue Growth 2017-2022 ($ Millions)

Figure 61. GCC Country Biosimilars of Rituximab Revenue Growth 2017-2022 ($ Millions)

Figure 62. Manufacturing Cost Structure Analysis of Biosimilars of Rituximab in 2021

Figure 63. Manufacturing Process Analysis of Biosimilars of Rituximab

Figure 64. Industry Chain Structure of Biosimilars of Rituximab

Figure 65. Channels of Distribution

Figure 66. Distributors Profiles